Chemoinformaics analysis of Pyroglutamylglutamine
Molecular Weight | 257.246 | nRot | 6 |
Heavy Atom Molecular Weight | 242.126 | nRig | 7 |
Exact Molecular Weight | 257.101 | nRing | 1 |
Solubility: LogS | -1.158 | nHRing | 1 |
Solubility: LogP | -1.857 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 3 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 34.0119 |
nHD | 4 | BPOL | 19.0901 |
QED | 0.339 |
Synth | 3.534 |
Natural Product Likeliness | 0.157 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.434 |
HIA | 0.054 |
CACO-2 | -5.802 |
MDCK | 0.00178459 |
BBB | 0.911 |
PPB | 0.0785307 |
VDSS | 0.371 |
FU | 0.856924 |
CYP1A2-inh | 0.005 |
CYP1A2-sub | 0.036 |
CYP2c19-inh | 0.034 |
CYP2c19-sub | 0.041 |
CYP2c9-inh | 0.015 |
CYP2c9-sub | 0.839 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.128 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.018 |
CL | 3.62 |
T12 | 0.753 |
hERG | 0.018 |
Ames | 0.018 |
ROA | 0.002 |
SkinSen | 0.071 |
Carcinogencity | 0.026 |
EI | 0.015 |
Respiratory | 0.293 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.765624 |